Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Clinical trial NCT06141369 · RECRUITING

Trial details

NCT number: NCT06141369
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Adrenal Cortical Carcinoma Medullary Thyroid Cancer Thymic Neuroendocrine Carcinoma Pancreatic Neuroendocrine Tumor

Start date: 2024-01-13
Primary completion: 2026-12-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.